Volume | 339,980 |
|
|||||
News | - | ||||||
Day High | 8.66 | Low High |
|||||
Day Low | 8.00 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
8.29 | 8.00 | 8.66 | 8.17 | 8.20 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,177 | 339,980 | $ 8.27 | $ 2,809,952 | - | 4.004 - 40.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:49:29 | 5 | $ 8.48 | USD |
Outlook Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
106.32M | 13.01M | - | 0 | -58.98M | -4.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Outlook Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.93 | 9.26 | 7.80 | 8.33 | 257,362 | -0.73 | -8.17% |
1 Month | 9.36 | 12.8499 | 7.80 | 9.67 | 547,249 | -1.16 | -12.39% |
3 Months | 8.556 | 12.8499 | 5.0401 | 8.46 | 1,481,142 | -0.356 | -4.16% |
6 Months | 8.91 | 13.322 | 5.00 | 8.73 | 2,845,006 | -0.71 | -7.97% |
1 Year | 23.00 | 40.60 | 4.004 | 10.75 | 4,075,818 | -14.80 | -64.35% |
3 Years | 42.60 | 65.40 | 4.004 | 20.20 | 2,135,725 | -34.40 | -80.75% |
5 Years | 31.00 | 85.20 | 4.004 | 26.56 | 2,141,144 | -22.80 | -73.55% |
Outlook Therapeutics Description
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |